Biotechnology - Thousand Oaks, California, US
Preclinical biotechnology company leveraging proprietary structure-based technology to develop small molecule disaggregators and inhibitors targeting previously undruggable misfolded proteins in neurodegenerative diseases. Our pipeline consists of tau, TDP-43 and alpha-synuclein programs.
Varnish
Wix
Google Cloud Hosting
Mobile Friendly